UniProt ID | MBD3_HUMAN | |
---|---|---|
UniProt AC | O95983 | |
Protein Name | Methyl-CpG-binding domain protein 3 | |
Gene Name | MBD3 | |
Organism | Homo sapiens (Human). | |
Sequence Length | 291 | |
Subcellular Localization | Nucleus. Chromosome. Nuclear, in discrete foci. Detected on chromatin, at promoter regions of active genes. | |
Protein Description | Acts as transcriptional repressor and plays a role in gene silencing. Does not bind to DNA by itself. [PubMed: 12124384 Binds to DNA with a preference for sites containing methylated CpG dinucleotides (in vitro Binds to a lesser degree DNA containing unmethylated CpG dinucleotides] | |
Protein Sequence | MERKRWECPALPQGWEREEVPRRSGLSAGHRDVFYYSPSGKKFRSKPQLARYLGGSMDLSTFDFRTGKMLMSKMNKSRQRVRYDSSNQVKGKPDLNTALPVRQTASIFKQPVTKITNHPSNKVKSDPQKAVDQPRQLFWEKKLSGLNAFDIAEELVKTMDLPKGLQGVGPGCTDETLLSAIASALHTSTMPITGQLSAAVEKNPGVWLNTTQPLCKAFMVTDEDIRKQEELVQQVRKRLEEALMADMLAHVEELARDGEAPLDKACAEDDDEEDEEEEEEEPDPDPEMEHV | |
Overview of Protein Modification Sites with Functional and Structural Information | ||
|
* ASA = Accessible Surface Area
Locations | Modification | Substrate Peptides & Secondary Structure |
ASA (%) | Reference | Orthologous Protein Cluster |
---|---|---|---|---|---|
4 | Acetylation | ----MERKRWECPAL ----CCCCCCCCCCC | 48.86 | - | |
4 (in isoform 2) | Acetylation | - | 48.86 | - | |
5 (in isoform 2) | Phosphorylation | - | 40.42 | 29514088 | |
7 (in isoform 2) | Phosphorylation | - | 34.36 | 29514088 | |
9 (in isoform 2) | Acetylation | - | 25.89 | - | |
20 | Phosphorylation | QGWEREEVPRRSGLS CCCCHHCCCCCCCCC | 3.71 | 32142685 | |
24 | Phosphorylation | REEVPRRSGLSAGHR HHCCCCCCCCCCCCC | 45.42 | 12354758 | |
35 | Phosphorylation | AGHRDVFYYSPSGKK CCCCCEEEECCCCCC | 11.68 | 29396449 | |
36 | Phosphorylation | GHRDVFYYSPSGKKF CCCCEEEECCCCCCC | 11.57 | 21712546 | |
36 | Ubiquitination | GHRDVFYYSPSGKKF CCCCEEEECCCCCCC | 11.57 | 24816145 | |
37 | Phosphorylation | HRDVFYYSPSGKKFR CCCEEEECCCCCCCC | 10.95 | 23401153 | |
39 | Phosphorylation | DVFYYSPSGKKFRSK CEEEECCCCCCCCCC | 58.25 | 21815630 | |
41 | Ubiquitination | FYYSPSGKKFRSKPQ EEECCCCCCCCCCHH | 53.74 | 32142685 | |
45 | Phosphorylation | PSGKKFRSKPQLARY CCCCCCCCCHHHHHH | 52.39 | - | |
52 | Phosphorylation | SKPQLARYLGGSMDL CCHHHHHHHCCCCCC | 12.23 | 28464451 | |
56 | Phosphorylation | LARYLGGSMDLSTFD HHHHHCCCCCCCCCC | 13.81 | 22617229 | |
58 | Ubiquitination | RYLGGSMDLSTFDFR HHHCCCCCCCCCCHH | 38.88 | 29967540 | |
60 | Ubiquitination | LGGSMDLSTFDFRTG HCCCCCCCCCCHHHH | 23.82 | 24816145 | |
60 | Phosphorylation | LGGSMDLSTFDFRTG HCCCCCCCCCCHHHH | 23.82 | 30108239 | |
61 | Phosphorylation | GGSMDLSTFDFRTGK CCCCCCCCCCHHHHH | 34.22 | 30108239 | |
66 | Phosphorylation | LSTFDFRTGKMLMSK CCCCCHHHHHHHHHH | 40.94 | - | |
68 | Ubiquitination | TFDFRTGKMLMSKMN CCCHHHHHHHHHHHH | 28.40 | 24816145 | |
73 | Sumoylation | TGKMLMSKMNKSRQR HHHHHHHHHHHHCCC | 32.31 | 28112733 | |
73 | Ubiquitination | TGKMLMSKMNKSRQR HHHHHHHHHHHHCCC | 32.31 | - | |
77 | Phosphorylation | LMSKMNKSRQRVRYD HHHHHHHHCCCEECC | 28.74 | 19664994 | |
83 | Phosphorylation | KSRQRVRYDSSNQVK HHCCCEECCCCCCCC | 19.81 | 21955146 | |
85 | Phosphorylation | RQRVRYDSSNQVKGK CCCEECCCCCCCCCC | 23.43 | 25159151 | |
86 | Phosphorylation | QRVRYDSSNQVKGKP CCEECCCCCCCCCCC | 28.52 | 23401153 | |
90 | Sumoylation | YDSSNQVKGKPDLNT CCCCCCCCCCCCHHC | 51.99 | 28112733 | |
90 | Acetylation | YDSSNQVKGKPDLNT CCCCCCCCCCCCHHC | 51.99 | 26051181 | |
90 | Ubiquitination | YDSSNQVKGKPDLNT CCCCCCCCCCCCHHC | 51.99 | 29967540 | |
92 | Sumoylation | SSNQVKGKPDLNTAL CCCCCCCCCCHHCCC | 29.64 | 28112733 | |
92 | Ubiquitination | SSNQVKGKPDLNTAL CCCCCCCCCCHHCCC | 29.64 | 24816145 | |
97 | Phosphorylation | KGKPDLNTALPVRQT CCCCCHHCCCCHHHH | 36.55 | 21712546 | |
106 | Phosphorylation | LPVRQTASIFKQPVT CCHHHHHHHHHCCCE | 31.76 | 24719451 | |
109 | Ubiquitination | RQTASIFKQPVTKIT HHHHHHHHCCCEECC | 52.61 | 21890473 | |
109 | Acetylation | RQTASIFKQPVTKIT HHHHHHHHCCCEECC | 52.61 | 19608861 | |
109 | Sumoylation | RQTASIFKQPVTKIT HHHHHHHHCCCEECC | 52.61 | - | |
109 | Sumoylation | RQTASIFKQPVTKIT HHHHHHHHCCCEECC | 52.61 | - | |
109 (in isoform 2) | Ubiquitination | - | 52.61 | 21890473 | |
110 | Ubiquitination | QTASIFKQPVTKITN HHHHHHHCCCEECCC | 27.26 | 22817900 | |
125 | Ubiquitination | HPSNKVKSDPQKAVD CCCCCCCCCHHHHCC | 58.47 | 32015554 | |
129 | Ubiquitination | KVKSDPQKAVDQPRQ CCCCCHHHHCCCHHH | 56.62 | - | |
141 | Acetylation | PRQLFWEKKLSGLNA HHHHHHHHHCCCCCH | 50.00 | 23749302 | |
141 | Ubiquitination | PRQLFWEKKLSGLNA HHHHHHHHHCCCCCH | 50.00 | 22817900 | |
141 (in isoform 1) | Ubiquitination | - | 50.00 | 21890473 | |
142 | Ubiquitination | RQLFWEKKLSGLNAF HHHHHHHHCCCCCHH | 36.05 | 22817900 | |
144 | Phosphorylation | LFWEKKLSGLNAFDI HHHHHHCCCCCHHHH | 50.55 | 25159151 | |
157 | Ubiquitination | DIAEELVKTMDLPKG HHHHHHHHHCCCCCC | 51.24 | 32015554 | |
184 | Ubiquitination | LLSAIASALHTSTMP HHHHHHHHHHHCCCC | 8.37 | 32015554 | |
195 | Ubiquitination | STMPITGQLSAAVEK CCCCCCCCHHHHHHH | 24.48 | 33845483 | |
216 | Ubiquitination | NTTQPLCKAFMVTDE ECCCHHHHHHCCCHH | 52.95 | 32015554 | |
219 | Sulfoxidation | QPLCKAFMVTDEDIR CHHHHHHCCCHHHHH | 3.66 | 21406390 | |
221 | Phosphorylation | LCKAFMVTDEDIRKQ HHHHHCCCHHHHHHH | 23.14 | - | |
227 | Ubiquitination | VTDEDIRKQEELVQQ CCHHHHHHHHHHHHH | 63.50 | 33845483 |
Modified Location | Modified Residue | Modification | Function | Reference | ||
---|---|---|---|---|---|---|
Oops, there are no descriptions of PTM sites of MBD3_HUMAN !! |
* Distance = the distance between SAP position and PTM sites.
Modified Location | Modification | Variant Position (Distance <= 10) |
Residue Change | SAP | Related Disease | Reference |
---|---|---|---|---|---|---|
Oops, there are no SNP-PTM records of MBD3_HUMAN !! |
Kegg Disease | ||||||
---|---|---|---|---|---|---|
There are no disease associations of PTM sites. | ||||||
OMIM Disease | ||||||
There are no disease associations of PTM sites. | ||||||
Kegg Drug | ||||||
There are no disease associations of PTM sites. | ||||||
DrugBank | ||||||
There are no disease associations of PTM sites. |
loading...
Acetylation | |
Reference | PubMed |
"Lysine acetylation targets protein complexes and co-regulates majorcellular functions."; Choudhary C., Kumar C., Gnad F., Nielsen M.L., Rehman M., Walther T.,Olsen J.V., Mann M.; Science 325:834-840(2009). Cited for: ACETYLATION [LARGE SCALE ANALYSIS] AT LYS-4; LYS-109 AND LYS-141, ANDMASS SPECTROMETRY. | |
Phosphorylation | |
Reference | PubMed |
"Quantitative phosphoproteomic analysis of T cell receptor signalingreveals system-wide modulation of protein-protein interactions."; Mayya V., Lundgren D.H., Hwang S.-I., Rezaul K., Wu L., Eng J.K.,Rodionov V., Han D.K.; Sci. Signal. 2:RA46-RA46(2009). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-56 AND SER-144, AND MASSSPECTROMETRY. | |
"A quantitative atlas of mitotic phosphorylation."; Dephoure N., Zhou C., Villen J., Beausoleil S.A., Bakalarski C.E.,Elledge S.J., Gygi S.P.; Proc. Natl. Acad. Sci. U.S.A. 105:10762-10767(2008). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-56, AND MASSSPECTROMETRY. |